AAAAAA

   
Results: 1-12 |
Results: 12
ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION
Authors: FRIEDRICHS GS ABREU JN DRISCOLL EM BORLAK J LUCCHESI BR
Citation: Gs. Friedrichs et al., ANTIFIBRILLATORY EFFICACY OF LONG-TERM TEDISAMIL ADMINISTRATION IN A POSTINFARCTED CANINE MODEL OF ISCHEMIC VENTRICULAR-FIBRILLATION, Journal of cardiovascular pharmacology, 31(1), 1998, pp. 56-66
EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION
Authors: BLACK SC DRISCOLL EM LUCCHESI BR
Citation: Sc. Black et al., EFFECT OF RAMIPRILAT OR CAPTOPRIL ON MYOCARDIAL INFARCT SIZE - ASSESSMENT IN CANINE MODELS OF ISCHEMIA ALONE AND ISCHEMIA WITH REPERFUSION, Pharmacology, 57(1), 1998, pp. 35-46
TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
Authors: REBELLO SS DRISCOLL EM LUCCHESI BR
Citation: Ss. Rebello et al., TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/, Stroke, 28(9), 1997, pp. 1789-1796
EFFECTS OF A SINGLE ADMINISTRATION OF HEPARIN OR N-ACETYLHEPARIN (NHEP) 2 HOURS BEFORE REGIONAL ISCHEMIA AND REPERFUSION IN A CANINE MODEL OF IRREVERSIBLE MYOCARDIAL INJURY
Authors: GRALINSKI MR FRIEDRICHS GS DRISCOLL EM LUCCHESI BR
Citation: Mr. Gralinski et al., EFFECTS OF A SINGLE ADMINISTRATION OF HEPARIN OR N-ACETYLHEPARIN (NHEP) 2 HOURS BEFORE REGIONAL ISCHEMIA AND REPERFUSION IN A CANINE MODEL OF IRREVERSIBLE MYOCARDIAL INJURY, The FASEB journal, 9(3), 1995, pp. 9-9
EFFECTS OF BMY21190, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, ON INFARCT SIZE AND MYELOPEROXIDASE ACTIVITY IN THE ISCHEMIC MYOCARDIUM OF A CANINE OCCLUSION-REPERFUSION MODEL
Authors: MINAMI M DRISCOLL EM SIMPSON PJ HOFF PT LUCCHESI BR
Citation: M. Minami et al., EFFECTS OF BMY21190, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, ON INFARCT SIZE AND MYELOPEROXIDASE ACTIVITY IN THE ISCHEMIC MYOCARDIUM OF A CANINE OCCLUSION-REPERFUSION MODEL, Pharmacology, 50(1), 1995, pp. 24-33
INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC SUPEROXIDE-DISMUTASE (SOD) MIMETIC
Authors: DRISCOLL EM BLACK SC SCHASTEEN CS WEISS RH RILEY DP
Citation: Em. Driscoll et al., INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC SUPEROXIDE-DISMUTASE (SOD) MIMETIC, The FASEB journal, 8(5), 1994, pp. 10000606-10000606
CARDIOPROTECTIVE EFFECTS OF N-ACETYLHEPARIN (NHEP) IN A CANINE MODEL OF ISCHEMIA AND REPERFUSION INJURY
Authors: BLACK SC GRALINSKI MR FRIEDRICHS GS KILGORE KS DRISCOLL EM LUCCHESI BR
Citation: Sc. Black et al., CARDIOPROTECTIVE EFFECTS OF N-ACETYLHEPARIN (NHEP) IN A CANINE MODEL OF ISCHEMIA AND REPERFUSION INJURY, The FASEB journal, 8(4), 1994, pp. 10000559-10000559
EFFECT OF RANOLAZINE ON INFARCT SIZE IN A CANINE MODEL OF REGIONAL MYOCARDIAL ISCHEMIA REPERFUSION/
Authors: BLACK SC GRALINSKI MR MCCORMACK JG DRISCOLL EM LUCCHESI BR
Citation: Sc. Black et al., EFFECT OF RANOLAZINE ON INFARCT SIZE IN A CANINE MODEL OF REGIONAL MYOCARDIAL ISCHEMIA REPERFUSION/, Journal of cardiovascular pharmacology, 24(6), 1994, pp. 921-928
INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC MANGANESE-BASED SUPEROXIDE-DISMUTASE MIMETIC
Authors: BLACK SC SCHASTEEN CS WEISS RH RILEY DP DRISCOLL EM LUCCHESI BR
Citation: Sc. Black et al., INHIBITION OF IN-VIVO MYOCARDIAL ISCHEMIC AND REPERFUSION INJURY BY ASYNTHETIC MANGANESE-BASED SUPEROXIDE-DISMUTASE MIMETIC, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1208-1215
PREVENTION OF THROMBOSIS AND RETHROMBOSIS AND ENHANCEMENT OF THE THROMBOLYTIC ACTIONS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE CANINE HEART BY DMP728, A GLYCOPROTEIN IIB IIIA ANTAGONIST/
Authors: LUCCHESSI BR ROTE WE DRISCOLL EM MU DX
Citation: Br. Lucchessi et al., PREVENTION OF THROMBOSIS AND RETHROMBOSIS AND ENHANCEMENT OF THE THROMBOLYTIC ACTIONS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE CANINE HEART BY DMP728, A GLYCOPROTEIN IIB IIIA ANTAGONIST/, British Journal of Pharmacology, 113(4), 1994, pp. 1333-1343
INHIBITION OF CORONARY-ARTERY REOCCLUSION AFTER THROMBOLYSIS WITH AN RGD-CONTAINING PEPTIDE WITH NO SIGNIFICANT EFFECT ON BLEEDING-TIME
Authors: TSCHOPP JF DRISCOLL EM MU DX BLACK SC PIERSCHBACHER MD LUCCHESI BR
Citation: Jf. Tschopp et al., INHIBITION OF CORONARY-ARTERY REOCCLUSION AFTER THROMBOLYSIS WITH AN RGD-CONTAINING PEPTIDE WITH NO SIGNIFICANT EFFECT ON BLEEDING-TIME, Coronary artery disease, 4(9), 1993, pp. 809-817
ANTITHROMBOTIC EFFECTS OF BMY21190, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: MINAMI M DRISCOLL EM LUCCHESI BR
Citation: M. Minami et al., ANTITHROMBOTIC EFFECTS OF BMY21190, AN INHIBITOR OF CAMP-PHOSPHODIESTERASE, IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, Japanese Circulation Journal, 57(10), 1993, pp. 979-992
Risultati: 1-12 |